Advanced search
1 file | 503.58 KB Add to list

Transmasculine hormone therapy

Justine Defreyne (UGent) and Guy T'Sjoen (UGent)
Author
Organization
Abstract
Prescribing gender-affirming hormonal therapy in transgender men (TM) not only induces desirable physical effects but also benefits mental health. In TM, testosterone therapy is aimed at achieving cisgender male serum testosterone to induce virilization. Testosterone therapy is safe on the short term and middle term if adequate endocrinological follow-up is provided. Transgender medicine is not a strong part of the medical curriculum, although a large number of transgender persons will search for some kind of gender-affirming care. Because hormonal therapy has beneficial effects, all endocrinologists or hormone-prescribing physicians should be able to provide gender-affirming hormonal care.
Keywords
Testosterone, Gender-affirming hormones, Transgender men, Safety, Follow-up, BONE-MINERAL DENSITY, TO-MALE TRANSSEXUALS, QUALITY-OF-LIFE, INTRAMUSCULAR TESTOSTERONE UNDECANOATE, TERM-FOLLOW-UP, BREAST-CANCER, SEX REASSIGNMENT, TRANSGENDER INDIVIDUALS, TRANS PERSONS, CARDIOVASCULAR-DISEASE

Downloads

  • (...).pdf
    • full text (Published version)
    • |
    • UGent only
    • |
    • PDF
    • |
    • 503.58 KB

Citation

Please use this url to cite or link to this publication:

MLA
Defreyne, Justine, and Guy T’Sjoen. “Transmasculine Hormone Therapy.” ENDOCRINOLOGY AND METABOLISM CLINICS OF NORTH AMERICA, vol. 48, no. 2, 2019, pp. 357–75.
APA
Defreyne, J., & T’Sjoen, G. (2019). Transmasculine hormone therapy. ENDOCRINOLOGY AND METABOLISM CLINICS OF NORTH AMERICA, 48(2), 357–375.
Chicago author-date
Defreyne, Justine, and Guy T’Sjoen. 2019. “Transmasculine Hormone Therapy.” ENDOCRINOLOGY AND METABOLISM CLINICS OF NORTH AMERICA 48 (2): 357–75.
Chicago author-date (all authors)
Defreyne, Justine, and Guy T’Sjoen. 2019. “Transmasculine Hormone Therapy.” ENDOCRINOLOGY AND METABOLISM CLINICS OF NORTH AMERICA 48 (2): 357–375.
Vancouver
1.
Defreyne J, T’Sjoen G. Transmasculine hormone therapy. ENDOCRINOLOGY AND METABOLISM CLINICS OF NORTH AMERICA. 2019;48(2):357–75.
IEEE
[1]
J. Defreyne and G. T’Sjoen, “Transmasculine hormone therapy,” ENDOCRINOLOGY AND METABOLISM CLINICS OF NORTH AMERICA, vol. 48, no. 2, pp. 357–375, 2019.
@article{8653703,
  abstract     = {{Prescribing gender-affirming hormonal therapy in transgender men (TM) not only induces desirable physical effects but also benefits mental health. In TM, testosterone therapy is aimed at achieving cisgender male serum testosterone to induce virilization. Testosterone therapy is safe on the short term and middle term if adequate endocrinological follow-up is provided. Transgender medicine is not a strong part of the medical curriculum, although a large number of transgender persons will search for some kind of gender-affirming care. Because hormonal therapy has beneficial effects, all endocrinologists or hormone-prescribing physicians should be able to provide gender-affirming hormonal care.}},
  author       = {{Defreyne, Justine and T'Sjoen, Guy}},
  issn         = {{0889-8529}},
  journal      = {{ENDOCRINOLOGY AND METABOLISM CLINICS OF NORTH AMERICA}},
  keywords     = {{Testosterone,Gender-affirming hormones,Transgender men,Safety,Follow-up,BONE-MINERAL DENSITY,TO-MALE TRANSSEXUALS,QUALITY-OF-LIFE,INTRAMUSCULAR TESTOSTERONE UNDECANOATE,TERM-FOLLOW-UP,BREAST-CANCER,SEX REASSIGNMENT,TRANSGENDER INDIVIDUALS,TRANS PERSONS,CARDIOVASCULAR-DISEASE}},
  language     = {{eng}},
  number       = {{2}},
  pages        = {{357--375}},
  title        = {{Transmasculine hormone therapy}},
  url          = {{http://dx.doi.org/10.1016/j.ecl.2019.01.004}},
  volume       = {{48}},
  year         = {{2019}},
}

Altmetric
View in Altmetric
Web of Science
Times cited: